A. Díaz

Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain

C. Muñoz-Almagro, P. Ciruela, R. Sá-Leão, 2016, PloS one.

Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Epidemic and Nonepidemic Influenza Periods

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2019, Journal of Clinical Microbiology.

Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine.

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2021, Anales de pediatria.

Indirect effects of Paediatric Conjugate Vaccines on Invasive Pneumococcal Disease in Older Adults.

Montse Morta, M. Curriu, M. Benítez, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2017, PloS one.

Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2020, Emerging infectious diseases.

Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13

M. Benítez, C. Muñoz-Almagro, P. Ciruela, 2021, Microbiology spectrum.

Pneumococcal serotypes in children and relationship with clinical presentation and antimicrobial susceptibility in the PCV13 era

P. Ciruela, A. Planes, S. Uriona, 2019 .

[Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine].

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2021, Anales de pediatria.